23 . 09 .2026
Press release
EADV 2026: Galderma to unveil new data advancing understanding of skin diseases, skin longevity, and real-world patient experiences
21 . 09 .2026
Press release
Galderma begins trading in the Swiss Market Index, joining Switzerland's leading blue chip companies
16 . 09 .2026
Press release
Galderma’s Restylane® Volyme™ demonstrates high effectiveness, satisfaction and a robust safety profile in Chinese patients with temple hollowing
11 . 08 .2026
Press release
Galderma receives European Union approval for Restylane® Shaype™: the first-and-only bone-mimicking hyaluronic acid injectable for facial shaping
05 . 08 .2026
Press release
Galderma expands Cetaphil's Nourishing Line with new body care innovations, delivering clinically proven glow through advanced barrier science
23 . 07 .2026
Press release
Galderma reports record first half 2026 net sales of 3.134 billion USD and 24.6% year-on-year growth at constant currency, raises net sales guidance for the full year
20 . 07 .2026
Press release
Galderma launches Alastin® in Japan and key markets across Asia Pacific, expanding its footprint in the region
07 . 07 .2026
Press release
Landmark global Galderma survey shows 9 out of 10 people are affected by skin quality concerns